Predictive role of circulating tumor DNA based molecular residual disease for long-term outcomes in non-small cell lung cancer patients: a meta-analysis
OncologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- World journal of surgical oncology
- Publicado em
- 13 jun 2025
- Citações
- 3
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Predictive role of circulating tumor DNA based molecular residual disease for long-term outcomes in non-small cell lung cancer patients: a meta-analysis
Siyuan Che, Dongliang Yu
Descritores MeSH
- Circulating Tumor DNA
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Biomarkers, Tumor
- Neoplasm, Residual
- Humans
- Survival Rate
- Prognosis
Veja também
Estudos relacionados
- Prognostic significance of circulating tumor DNA as a baseline or dynamic factor in advanced NSCLC without oncogenic drivers: A systematic review and meta-analysis
- Prognostic and clinicopathological value of myeloid-derived suppressor cells in lung cancer: a comprehensive systematic review and meta-analysis
- The prognostic role of circulating DNA markers in patients with lung malignancies: a systematic review and meta-analysis
- Cerebrospinal fluid Circulating Tumor DNA (ctDNA) as a biomarker for CNS metastases in Non-Small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis comparing CSF ctDNA and traditional methods